Business Description
Precision BioSciences Inc
NAICS : 325412
SIC : 2834
ISIN : US74019P1084
Description
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.34 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.47 | |||||
| Debt-to-EBITDA | 1.61 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -2.46 | |||||
| Beneish M-Score | -0.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.2 | |||||
| 3-Year EBITDA Growth Rate | 47.4 | |||||
| 3-Year EPS without NRI Growth Rate | 43.6 | |||||
| 3-Year FCF Growth Rate | 25 | |||||
| 3-Year Book Growth Rate | -43.6 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.08 | |||||
| 9-Day RSI | 31.92 | |||||
| 14-Day RSI | 30.99 | |||||
| 6-1 Month Momentum % | -27.57 | |||||
| 12-1 Month Momentum % | -31.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.22 | |||||
| Quick Ratio | 9.22 | |||||
| Cash Ratio | 8.45 | |||||
| Days Sales Outstanding | 5.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -33.3 | |||||
| Shareholder Yield % | -151.02 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -21.58 | |||||
| Net Margin % | 11.48 | |||||
| FCF Margin % | -64 | |||||
| ROE % | 19.19 | |||||
| ROA % | 5.21 | |||||
| ROIC % | -27.6 | |||||
| ROC (Joel Greenblatt) % | 110.21 | |||||
| ROCE % | 10.36 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 75 | |||||
| PS Ratio | 0.36 | |||||
| PB Ratio | 0.52 | |||||
| Price-to-Tangible-Book | 0.52 | |||||
| EV-to-EBIT | -2.71 | |||||
| EV-to-EBITDA | -1.93 | |||||
| EV-to-Forward-EBITDA | -0.09 | |||||
| EV-to-Revenue | -0.48 | |||||
| EV-to-Forward-Revenue | 0.1 | |||||
| EV-to-FCF | 0.75 | |||||
| Price-to-Net-Current-Asset-Value | 1.52 | |||||
| Price-to-Net-Cash | 2.63 | |||||
| Earnings Yield (Greenblatt) % | -36.9 | |||||
| FCF Yield % | -140.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Precision BioSciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 69.505 | ||
| EPS (TTM) (€) | 0.152 | ||
| Beta | 1.16 | ||
| Volatility % | 108.69 | ||
| 14-Day RSI | 30.99 | ||
| 14-Day ATR (€) | 0.32354 | ||
| 20-Day SMA (€) | 5.6245 | ||
| 12-1 Month Momentum % | -31.07 | ||
| 52-Week Range (€) | 3.96 - 17.44 | ||
| Shares Outstanding (Mil) | 7.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Precision BioSciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Precision BioSciences Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Precision BioSciences Inc Frequently Asked Questions
What is Precision BioSciences Inc(FRA:PBS0)'s stock price today?
The current price of FRA:PBS0 is €4.40. The 52 week high of FRA:PBS0 is €17.44 and 52 week low is €3.96.
When is next earnings date of Precision BioSciences Inc(FRA:PBS0)?
The next earnings date of Precision BioSciences Inc(FRA:PBS0) is 2025-03-27 Est..
Does Precision BioSciences Inc(FRA:PBS0) pay dividends? If so, how much?
Precision BioSciences Inc(FRA:PBS0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers